Skip to contentA
Axim Biotechnologies, Inc.
A
AXIMAxim Biotechnologies, Inc. Q1 2016 · 10-Q
Revenue$14.01K$14.01K— vs Q1 2015 Net Income-$954.10K-$954.10KN/M vs Q1 2015 EPS Diluted-$0.02-$0.02N/M vs Q1 2015 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Axim Biotechnologies, Inc. · CIK 1514946 · Engraved from SEC EDGAR
-$942,180
N/M
Operating Cash Flow-$193,201N/M Margins · derivedGross margin-8.6%
Operating margin-6727.5%
Net margin-6812.6%
ended Mar 31, 2016 · filed May 23, 2016 · 53 d after period end